Edwards Lifesciences Corp.
One Edwards Way
Irvine,
CA 92614
United States - Map
Phone: 949-250-2500
Fax: 949-250-2525
Web Site: http://www.edwards.com
| Edwards Lifesciences Corporation provides products and technologies designed to treat cardiovascular diseases. It provides products and technologies for heart valve therapy, critical care, cardiac surgery systems, and vascular disease. The company offers tissue heart valves, such as pericardial and porcine valves, as well as repair products, including annuloplasty rings and systems, which are used to replace or repair a patientÂ’s diseased or defective heart valve. It also provides hemodynamic monitoring equipment that is used to measure a patientÂ’s heart function in surgical and intensive care settings; and disposable pressure transducers, and central venous access products for fluid and drug delivery. In addition, the company offers cardiac surgery system products, including cannula, intra-aortic filtration systems, and other disposable products used during cardiopulmonary bypass procedures; and vascular products that include balloon-tipped and catheter-based embolectomy products, surgical clips, and clamps for use in the treatment of peripheral vascular disease. Edwards Lifesciences Corp. distributes its products through a direct sales force and independent distributors worldwide. It has a collaboration agreement with DexCom, Inc. to develop products for continuously monitoring blood glucose levels in patients hospitalized for various conditions. The company was founded in 1999 and is headquartered in Irvine, California. Edwards Lifesciences Corp. (NYSE:EW) operates independently of Baxter International Inc. as of March 31, 2000. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Michael A. Mussallem , 56
Chairman and Chief Exec. Officer |
$
2.40M |
$
6.45M | Mr. Thomas M. Abate , 56
Chief Financial Officer, Principal Accounting Officer, Corp. VP, Treasurer and Controller |
$
865.00K |
$
0 | Ms. Corinne H. Lyle , 48
Corp. VP of Cardiac Surgery Systems & Vascular and Gen. Mang. of Cardiac Surgery Systems & Vascular |
$
821.00K |
$
827.00K | Mr. Patrick B. Verguet , 51
Corp. VP of Europe |
$
896.00K |
$
92.00K | Mr. Carlyn D. Solomon , 46
Corp. VP of Critical Care |
$
734.00K |
$
0 |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.23% Nasdaq 
Profile
